BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 8395676)

  • 1. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity.
    Leone A; Flatow U; VanHoutte K; Steeg PS
    Oncogene; 1993 Sep; 8(9):2325-33. PubMed ID: 8395676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
    Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
    J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
    Ouatas T; Halverson D; Steeg PS
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and metastatic potential.
    Liu F; Zhang Y; Zhang XY; Chen HL
    J Cancer Res Clin Oncol; 2002 Apr; 128(4):189-96. PubMed ID: 11935309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased sensitivity to cisplatin by nm23-transfected tumor cell lines.
    Ferguson AW; Flatow U; MacDonald NJ; Larminat F; Bohr VA; Steeg PS
    Cancer Res; 1996 Jul; 56(13):2931-5. PubMed ID: 8674043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nm23 and tumour metastasis: basic and translational advances.
    Freije JM; MacDonald NJ; Steeg PS
    Biochem Soc Symp; 1998; 63():261-71. PubMed ID: 9513729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.
    Miyazaki H; Fukuda M; Ishijima Y; Takagi Y; Iimura T; Negishi A; Hirayama R; Ishikawa N; Amagasa T; Kimura N
    Clin Cancer Res; 1999 Dec; 5(12):4301-7. PubMed ID: 10632374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1].
    Che GW; Zhou QH; Zhu W; Wang YP; Qin Y; Liu LX; Chen XH; Sun YL; Sun ZF
    Ai Zheng; 2005 Mar; 24(3):278-84. PubMed ID: 15757527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
    Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
    Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23.
    Tseng YH; Vicent D; Zhu J; Niu Y; Adeyinka A; Moyers JS; Watson PH; Kahn CR
    Cancer Res; 2001 Mar; 61(5):2071-9. PubMed ID: 11280768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line.
    Baba H; Urano T; Okada K; Furukawa K; Nakayama E; Tanaka H; Iwasaki K; Shiku H
    Cancer Res; 1995 May; 55(9):1977-81. PubMed ID: 7728768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a second human nm23 gene, nm23-H2.
    Stahl JA; Leone A; Rosengard AM; Porter L; King CR; Steeg PS
    Cancer Res; 1991 Jan; 51(1):445-9. PubMed ID: 1988104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of the promoter for the human metastasis suppressor gene nm23-H1.
    de la Rosa A; Mikhak B; Steeg PS
    Arch Med Res; 1996; 27(3):395-401. PubMed ID: 8854401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
    Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS
    Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
    Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
    Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
    Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH
    Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells.
    Liu F; Qi HL; Chen HL
    J Cancer Res Clin Oncol; 2000 Feb; 126(2):85-90. PubMed ID: 10664247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of nm23 gene expression during the induced differentiation of human leukemia cell lines.
    Yamashiro S; Urano T; Shiku H; Furukawa K
    Oncogene; 1994 Sep; 9(9):2461-8. PubMed ID: 8058309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low expression of nm23-H1 mRNA and its protein in breast cancer].
    Guo W; Wang Y; Zhuang X; Bai Y; Zhang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):91-3. PubMed ID: 10751528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model.
    Ma D; Luyten GP; Luider TM; Jager MJ; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2293-301. PubMed ID: 8843913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.